Janakiraman Subramanian Profile
Janakiraman Subramanian

@RamSubraMD

Followers
233
Following
123
Media
6
Statuses
75

Co - Director of Thoracic Oncology. Inova Schar Cancer Institute. Director Data Analysis Research Core ISCI

Virginia, USA
Joined April 2020
Don't wanna be here? Send us removal request.
@RamSubraMD
Janakiraman Subramanian
2 years
Excellent work Dhruv.
@SLCI_KC
Saint Luke's Cancer Institute
2 years
Dr. Bansal keeps his ongoing research into patient subgroups that benefit from immunotherapy. Being presented at @sitcancer 2023 annual conference.
1
0
6
@SLCI_KC
Saint Luke's Cancer Institute
2 years
St Luke's precision oncology program reports improved outcomes for patients with @saintlukeskc molecular tumor board-directed therapy at the ESMO conference in Madrid
0
1
4
@RamSubraMD
Janakiraman Subramanian
2 years
Congrats Ben and I am sure more to come
@BPonvilawan
Ben Ponvilawan, MD, MS
2 years
Just published in JTO: https://t.co/SfaGyq2xMw STK11 and KEAP1 mutations confer less OS and PFS benefit in metastatic NSCLC, but ICI doublets might overcome the resistance. Thank you @RamSubraMD @dhruvsxu for guiding this project through!
0
0
2
@ChristianRolfo
Christian Rolfo
2 years
Continuing at MSL Arlington VA with Lung Cancer 🫁session with very comprehensive overview from great colleagues @VamsiVelcheti TKI @RamSubraMD IO and @NaglaAKarimMD resistance. An amazing session chairing by my friend Amin Benyounnes @InovaSchar @mecmededucation @OncoAlert
2
3
12
@ChristianRolfo
Christian Rolfo
2 years
Very interesting update on Prostate Cancer Precision Oncology from my former colleague Dr. Arif Hussain from @UMBaltimore @UMGCCC at MSL Arlington @RamSubraMD @NaglaAKarimMD @InovaSchar @OncoAlert @isliquidbiopsy @mecmededucation
1
1
3
@RamSubraMD
Janakiraman Subramanian
2 years
Dr Ashiq Masood discussing molecular classification in colorectal cancer and the role of targeted therapy #MLSArlington @mecmededucation @ashiq_masood
0
0
4
@RamSubraMD
Janakiraman Subramanian
2 years
Dr Christian Rolfo giving a lecture on the recent advances in precision oncology and the role of liquid biopsy #MLSArlington @mecmededucation @ChristianRolfo
1
0
9
@RamSubraMD
Janakiraman Subramanian
2 years
Dr Yacur giving a master lecture on the recent advances in breast cancer #MLS Arlington @mecmededucation @InovaSchar
0
0
3
@RamSubraMD
Janakiraman Subramanian
2 years
Getting started with MLS Arlington. Promises to be a great day of learning. @mecmededucation @CancerExpertNow
0
0
6
@RamSubraMD
Janakiraman Subramanian
2 years
Magical times on the Nile
@triparnasen
Triparna Sen (Sen-Lab)
2 years
2 weeks ago- a magical cruise on the Nile with my brilliant colleagues. A memorable evening of #friendship, #collaboration & #strategies to control #lungcancer. @NaglaAKarimMD @karenkellymd @maiofegypt @BrainTumorDoc @RamSubraMD #SCLC #WomenInSTEM #womeninthoraciconcology
0
1
3
@triparnasen
Triparna Sen (Sen-Lab)
2 years
Two days of phenomenal #science, #strategy, #DEI, #collaboration, & #friendship at the Annual Meeting of #ESRN #ECRN at Cairo. Enjoying the history and culture of Egypt with these amazing group of #physicians & #scientists. #lungcancer #diversity #MENASA #LCSM #SCLC #Inclusion
0
6
41
@triparnasen
Triparna Sen (Sen-Lab)
2 years
My job makes me meet wonderful people. In Cairo with @drgandara @NaglaAKarimMD @karenkellymd @RamSubraMD @BrainTumorDoc Phil Mack. Gearing up for discussing strategies about #lungcancer #SCLC #treatment #airpollution #precisionmedicine. #MENASA #Diversity #LCSM @IcahnMountSinai
0
6
20
@LuisERaez1
Luis E Raez
3 years
Our lung cancer session at 2023 #PRIMO Hawaii @medical_cons meeting with @EdgardoSantosMD jorge nieva @RamSubraMD #LCSM @OLACANCER1 @FLASCO_ORG #Immunotherapy #Immunology #lungcancer
0
3
13
@RamSubraMD
Janakiraman Subramanian
3 years
Dr @edgardo_ny discussing targeted therapy updates for patients with KRAS G12C, RET, BRAF, TRK alterations at #PRIMO2023
0
0
4
@Latinamd
Dr. Estela Rodriguez
3 years
Great talk by @RamSubraMD making the case that The Future of Lung Cancer Screening in High Risk Non-Smokers is already here! ➡️ family history, biomarkers can select non- smokers at risk #lcsm @FLASCO_ORG Early Lung Cancer Summit @LuisERaez1
1
5
17
@LuisERaez1
Luis E Raez
3 years
we started our 2023 @flasco Lung Early Summit with Drs Henshke, Yankelevitz, Subramanian and Silvestri @OLACANCER1 #lcsm @Latinamd @OncDocMJ #lungcancer
0
2
20
@RamSubraMD
Janakiraman Subramanian
3 years
Great summit with experts from different fields discussing lung cancer prevention and screening. All thanks to @LuisERaez1 @FLASCO_ORG for making it all happen.
@LuisERaez1
Luis E Raez
3 years
we started our 2023 @flasco Lung Early Summit with Drs Henshke, Yankelevitz, Subramanian and Silvestri @OLACANCER1 #lcsm @Latinamd @OncDocMJ #lungcancer
0
3
5
@LuisERaez1
Luis E Raez
3 years
Join us for the 2023 @flasco Early Lung Cancer Summit, with a special focus on the Challenges of Early Detection: CT Screening, Blood Biomarkers, and more. @ChristianRolfo @Latinamd @acmoorephd @OncDocMJ #lungcancerscreening #lungcancer #liquidbiopsy #lcsm
0
3
15
@mecmededucation
The Medical Educator Consortium
3 years
Coming this February! Have you signed up yet? | 8th Annual Practical Recommendations in Immuno & Molecular Oncology (PRIMO) Meeting | Honolulu, HI | February 22 – 25, 2023 For more information, click here: https://t.co/aZ7Zn8PxHG #PRIMO #oncology #cancerresearch #ce #credits
0
4
5
@chulkimMD
Chul Kim
3 years
Our case report is out #JTOCRR @JTOonline! Here we describe a patient with KRAS G12C-mutated lung adenocarcinoma and untreated brain metastases who achieved significant clinical and radiographical response to #sotorasib. https://t.co/vScFwdEPpV
1
11
51